Literature DB >> 16814325

Altered neurogenic and mechanical responses to acetylcholine, ATP and substance P in detrusor from rat with outlet obstruction.

C Pinna1, P Sanvito, L Puglisi.   

Abstract

The well-known side effects of anticholinergic compounds used to treat urinary incontinence caused by detrusor overactivity have addressed the interest on other pharmacological intervention. The purpose of the present work was to investigate the possible changes in purinergic and cholinergic components of parasympathetic neurotransmission in obstructed rat bladders with detrusor overactivity, and to examine the effect of the association of suramin, atropine and indomethacin on nerve-mediated responses to electrical field stimulation (EFS). Mechanical responses to exogenous acetylcholine, ATP and substance P were also evaluated. Altered sensitivities to acetylcholine and to the sensory neurotransmitter substance P, but unchanged sensitivity to the stable ATP analogue alpha,beta-methyleneATP were observed in bladders from obstructed rats. Suramin and atropine inhibited purinergic and cholinergic components of the neurogenic responses evoked by EFS in detrusor strips from control and obstructed rats. Interestingly, suramin enhanced the antagonistic effect of atropine on neurogenic responses of detrusor strips at all frequencies of stimulation tested. Our results suggest that the association between an antimuscarinic drug and an antagonist of P2X purinoceptors such as suramin might be helpful to reduce the therapeutic dosage of the antimuscarinic drug, along with its side effects. This approach may be of interest in the therapy of patients with bladder incontinence caused by detrusor overactivity, which do not even respond to a maximal dosage of antimuscarinic drug.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16814325     DOI: 10.1016/j.lfs.2006.03.035

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Beta adrenergic modulation of spontaneous microcontractions and electrical field-stimulated contractions in isolated strips of rat urinary bladder from normal animals and animals with partial bladder outflow obstruction.

Authors:  J I Gillespie; C Rouget; S Palea; C Granato; C Korstanje
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-06-07       Impact factor: 3.000

2.  Distinct subclassification of DRG neurons innervating the distal colon and glans penis/distal urethra based on the electrophysiological current signature.

Authors:  Kristofer K Rau; Jeffrey C Petruska; Brian Y Cooper; Richard D Johnson
Journal:  J Neurophysiol       Date:  2014-05-28       Impact factor: 2.714

3.  Role of Purinergic Signaling in Voiding Dysfunction.

Authors:  Yan Sun; Toby C Chai
Journal:  Curr Bladder Dysfunct Rep       Date:  2010-08-26

Review 4.  Research Findings on Overactive Bladder.

Authors:  Phani B Patra; Sayani Patra
Journal:  Curr Urol       Date:  2015-05-20

Review 5.  Purinergic signalling in the urinary tract in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

6.  Extracellular UDP enhances P2X-mediated bladder smooth muscle contractility via P2Y(6) activation of the phospholipase C/inositol trisphosphate pathway.

Authors:  Weiqun Yu; Xiaofeng Sun; Simon C Robson; Warren G Hill
Journal:  FASEB J       Date:  2013-01-29       Impact factor: 5.191

7.  Role of PKC and CaV1.2 in detrusor overactivity in a model of obesity associated with insulin resistance in mice.

Authors:  Luiz O Leiria; Carolina Sollon; Marina C Calixto; Letícia Lintomen; Fabíola Z Mónica; Gabriel F Anhê; Gilberto De Nucci; Angelina Zanesco; Andrew D Grant; Edson Antunes
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

8.  Urinary Bladder Dysfunction in Transgenic Sickle Cell Disease Mice.

Authors:  Mário Angelo Claudino; Luiz Osório Silveira Leiria; Fábio Henrique da Silva; Eduardo Costa Alexandre; Andre Renno; Fabiola Zakia Mónica; Gilberto de Nucci; Kleber Yotsumoto Fertrin; Edson Antunes; Fernando Ferreira Costa; Carla Fernanda Franco-Penteado
Journal:  PLoS One       Date:  2015-08-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.